Orphazyme A/S
DelistedCIK 1764791fmd_08NCXNQ626AMKJC9PA0C9XA5KQManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2018 to Dec 31, 2021, 4 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 36 |
| Research and development | 197 | 285 | 361 | 330 |
| Operating income | (232) | (336) | (609) | (633) |
| Interest expense | 3 | 7 | 29 | 11 |
| Income before taxes | (235) | (343) | (635) | (631) |
| Income tax expense | (6) | (6) | (2) | (5) |
| Net income from continuing operations | (230) | (337) | (633) | (627) |
| Net income | (230) | (337) | (633) | (627) |